Dollar General is a discount retailer. The company's consumables products includes paper and cleaning products, packaged food, perishables, snacks, health and beauty, pet, and tobacco products. The company's seasonal products include decorations, toys, batteries, small electronics, greeting cards, stationery, prepaid phones and accessories, gardening supplies, hardware, automotive and home office supplies. The company's home products include kitchen supplies, cookware, small appliances, light bulbs, storage containers, frames, candles, craft supplies and kitchen, bed and bath soft goods. The company's apparel includes casual everyday apparel, as well as socks, underwear, disposable diapers, shoes and accessories.

Genasys is a provider of communications solutions. The company's platform provides a multi-channel approach to deliver alerts, notifications, instructions and information before, during and after public safety threats, and critical events. The company's multi-channel approach includes: Long Range Acoustic Devices that project sirens and audible voice messages with exceptional vocal clarity; Critical Communications as a Service software that is a solution for sending SMS, text, email and social media messages to mobile devices in defined geographic areas, and; Integrated Solutions that span multiple hardware and software mobile notification channels so that information can be delivered to people.

Mid Penn Bancorp is a bank holding company. Through its subsidiary Mid Penn Bank (the Bank), the company is engaged in accepting deposits and loans. The Bank engages in commercial banking and trust business, making available to the community a range of financial services, including, but not limited to, mortgage and home equity loans, secured and unsecured commercial and consumer loans, lines of credit, construction financing, farm loans, community development and local government loans and various types of time and demand deposits. The Bank also provides other services such as online banking, telephone banking, cash management services, automated teller services and safe deposit boxes.

Soleno Therapeutics is focused on the development and commercialization of therapeutics for the treatment of rare diseases. The company's primary candidate, Diazoxide Choline Controlled Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company's research and development efforts are primarily focused on developing its primary candidate, DCCR tablets for the treatment of PWS, through late-stage clinical development.